2013 Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Trends, Metrics and Financials PR Newswire MUMBAI, India, February 21, 2013 MUMBAI, India, February 21, 2013 /PRNewswire/ -- Bharat Book Bureau ( http://www.bharatbook.com/healthcare-market-research-reports/complete-2012-13-induced-pluripotent-stem-cell-industry-report.html ) has recently added the market intelligence report titled " The Complete 2012-13 Induced Pluripotent Stem Cell Industry Report - Market Metrics, Dynamics, and Trends ." It provides strategic insights that guide the decision-making of companies that develop and manufacture induced pluripotent stem cell (iPSC) research products. (Logo: http://photos.prnewswire.com/prnh/20130128/590935 ) The market intelligence report presents financial metrics for the Induced Pluripotent Stem Cell Industry, as well as key findings discovered from surveying a global audience of iPSC researchers (293 respondents). It reveals iPSC product and industry trends with five-year projections; informs about iPSC grants, patents and publications; identifies profitable opportunities for producers of iPSC products, and presents critical insights into future tools that iPSC scientists will require. In addition, it clearly denotes preferred species for iPSC research, analyzes the competitive environment for iPSC research products, and breaks down market share by competitor - providing an overall view of the iPSC product landscape. iPSCs are adult stem cells that have been transformed into embryotic-like stem cells through the manipulation of gene expression and similar methods. Despite some initial concerns, induced pluripotent stem cells (iPSC) are now sold by more than half (53.4%) of U.S. research product companies and 38.7% of research product companies worldwide. "It is clear that iPSC products are in high demand within the scientific community. Currently, it is difficult for stem cell research product suppliers, like BD BioSciences, Life Technologies, and others, to know what products iPSC scientists will demand in 2013 and beyond. The needs of scientists are constantly changing, so this market intelligence report reveals profitable opportunities for providers of iPSC research products to pursue," says BioInformant. For the past five decades, stem cell research has provided insights to the inner workings of the body and cell regeneration. "Therapeutic applications of iPSCs represent the future of medicine," says BioInformant. The scientific community believes that one day stem cell research will assist in finding viable treatments for crippling diseases such as Parkinson's, Alzheimer's, spinal cord injuries and more. "This is a must-read industry report for research supply companies to optimally position themselves to sell iPSC research products. This is a lucrative and rapidly expanding market," explains BioInformant. "The study will help you understand your key strengths relative to the competition." The study is backed by a 100% money back guarantee, to ensure that the strategies, findings and tools are found helpful. To learn more about "The Complete 2012-13 Induced Pluripotent Stem Cell Industry Report - Market Metrics, Dynamics, and Trends," please visit http://www.bharatbook.com/healthcare-market-research-reports/complete-2012-13-induced-pluripotent-stem-cell-industry-report.html for details. Request for Sample pages - http://www.bharatbook.com/RequestSample.asp?pid=331461 Table ofContents I. Abstract II. Background III. Timeline IV. Research Applications V. Characterization Of iPSC Research Advances VI. Companies Selling iPSC Research Products VII. Types Of iPSC Research Products VIII. Companies Developing iPSC Therapies A. Commerical Entities 1. ViaCyte 2. Fate Therapeutic 3. iPerian 4. Cellular Dynamics 5. Mesoblast B. Non-Commercial Organizations Developing iPSC Therapies IX. Strategic Collaborations For Development OF iPSC Products A. Life Technologies B. Lonza Group AG C. EMD Millipore D. Sigma Aldrich E. Roslin Cells, Ltd. F. ArunA Biomedical G . CeeTox and Cellular Dynamics X. Market Trend Analysis X. Market Size XII. Scientist Panel: Detailed End-User Survey XIII. Strategies For Accessing The Marketplace XIV. Conclusions Get an overview of the report at or request for sample pages at - http://www.bharatbook.com/healthcare-market-research-reports/complete-2012-13-induced-pluripotent-stem-cell-industry-report.html For Complete range of Related Reports: Stem Cells - http://www.bharatbook.com/StemCells.html Clinical Trial - http://www.bharatbook.com/ClinicalTrial Pharmaceutical & Healthcare - http://www.bharatbook.comPharmaceuticals-and-Healthcare.html About Bharat Book Bureau Bharat Book Bureau is the leading market research information aggregator that provides market research reports, industry analysis, company profiles, business reports, country reports, newsletters and online databases. Our clients include Corporate, Consulting firms, and Academic Institutions and Government departments across the globe. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. The market research reports we provide, help global companies examine the different markets before setting up a business or expanding into different countries across the world. They give a complete perspective on the current market scenario, trends, segments and future outlook. Contact us: Poonam Bharat Book BureauIndia : +91-22-27810772, 27810773USA/Canada - 1-866-279-8368 (Toll free) Skype - bharatbook E-mail : email@example.com Website : http://www.bharatbook.com
2013 Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Trends, Metrics and Financials
Press spacebar to pause and continue. Press esc to stop.